Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
Clinical trial NCT03709719 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03709719
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-20
- Primary completion
- 2026-10-30
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.